Bold Insight and The Office of Experience partner to deliver outstanding user experiences.
Back to team page
Chris Goesel
UX Researcher, Clinical Liaison
Chris brings a unique skillset as a registered nurse with 17+ years of clinical experience in orthopedics and medical-surgical settings and a background as a charge nurse on behavioral health units. Moderating numerous medical device studies, she applies real-world expertise to test preparation and lab design. Her goal is to build rapport with participants and put them at ease the moment she meets them. Chris believes in active listening and creating a safe, non-judgmental environment to help participants engage and provide feedback on a deeper level. She has a BS in Nursing from Lewis University.
Bold facts
Learn more about

Something unique about you summed up in one sentence

Your favorite part of working at Bold Insight

In your spare time (or if you had spare time), you would absolutely do this:
How long have you been in the UX field?
Your favorite city in the world is...and why?

Your ultimate celebrity dinner party guest list would include:

Long-term personal or professional goal?

Any other facts to share?
Read our team’s latest bold insights
When designing an experience, are you really thinking about the customer first?
While every organization has constraints to consider when designing experiences for customers or users, designing the ideal customer experience is completely possible within those constraints. Begin by identifying the experience you want your customer to have and work “backward” from there.
UX project logistics: choosing the right vendors for project success
Selecting the correct vendors to support your UX project is critical to success. From facilities to recruiting, knowing the right questions to ask, budget constraints, and client needs and expectations will make the selection process smooth and painless.
Reclassifying diabetes: 3 implications for product design
Recent research suggests that reclassifying diabetes may allow for the development of more targeted diabetes treatments. This could present opportunities to design these treatments to maximize patient safety and experience.